Works matching IS 00071048 AND DT 2013 AND VI 160 AND IP 6

Results: 22

Identification of novel polymorphism restricted to the (C)ce s type 1 haplotype avoids risk of transfusion deadlock in SCD patients.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 863, doi. 10.1111/bjh.12179

By:

Silvy, Monique;
Granier, Thomas;
Beley, Sophie;
Chiaroni, Jacques;
Bailly, Pascal

Publication type:

Article

The actin-binding protein CORO1A is a novel PU.1 ( SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 855, doi. 10.1111/bjh.12170

By:

Federzoni, Elena A.;
Humbert, Magali;
Valk, Peter J. M.;
Behre, Gerhard;
Leibundgut, Elisabeth O.;
Torbett, Bruce E.;
Fey, Martin F.;
Tschan, Mario P.

Publication type:

Article

Presenting D-dimer and early symptom severity are independent predictors for post-thrombotic syndrome following a first deep vein thrombosis.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 817, doi. 10.1111/bjh.12192

By:

Roberts, Lara N.;
Patel, Raj K.;
Chitongo, Paradzai B.;
Bonner, Lynda;
Arya, Roopen

Publication type:

Article

Multiple in silico tools predict phenotypic manifestations in congenital thrombotic thrombocytopenic purpura.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 825, doi. 10.1111/bjh.12214

By:

Hing, Zachary A.;
Schiller, Tal;
Wu, Andrew;
Hamasaki‐Katagiri, Nobuko;
Struble, Evi Budo;
Russek‐Cohen, Estelle;
Kimchi‐Sarfaty, Chava

Publication type:

Article

Corrigendum.

Published in:: British Journal of Haematology, 2013, v. 160, n. 6, p. 868, doi. 10.1111/bjh.12232
Publication type:: Article

Distinct involvement of NF-κB regulators by somatic mutation in ocular adnexal malt lymphoma.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 851, doi. 10.1111/bjh.12162

By:

Yan, Qingguo;
Wang, Ming;
Moody, Sarah;
Xue, Xuemin;
Huang, Yuanxue;
Bi, Yingwen;
Du, Ming‐Qing

Publication type:

Article

Neutrophil-specific granule deficiency.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 735, doi. 10.1111/bjh.12207

By:

McIlwaine, Louisa;
Parker, Anne;
Sandilands, Gavin;
Gallipoli, Paolo;
Leach, Mike

Publication type:

Article

Normal prothrombin time in the presence of therapeutic levels of rivaroxaban.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 859, doi. 10.1111/bjh.12173

By:

Veen, Joost J.;
Smith, Julie;
Kitchen, Steve;
Makris, Mike

Publication type:

Article

Haemorrhage and amyloidosis.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 854, doi. 10.1111/bjh.12166

By:

Veneri, Dino;
Pizzolo, Giovanni;
Bonalumi, Angela;
Franchini, Massimo

Publication type:

Article

How I manage priapism due to sickle cell disease.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 754, doi. 10.1111/bjh.12199

By:

Olujohungbe, Ade;
Burnett, Arthur L.

Publication type:

Article

Multiple cytokine- and chemokine-producing T-cell/histiocyte-rich large B-cell lymphoma.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 734, doi. 10.1111/bjh.12190

By:

Nakayama, Shoko;
Yokote, Taiji;
Hirata, Yuji;
Iwaki, Kazuki;
Tsuji, Motomu;
Hanafusa, Toshiaki

Publication type:

Article

Single nucleotide polymorphisms and the risk of venous thrombosis: results from a Danish case-cohort study.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 838, doi. 10.1111/bjh.12132

By:

El‐Galaly, Tarec C.;
Severinsen, Marianne T.;
Overvad, Kim;
Steffensen, Rudi;
Vistisen, Anders K.;
Tjønneland, Anne;
Kristensen, Søren R.

Publication type:

Article

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 842, doi. 10.1111/bjh.12217

By:

Davies, Carwyn;
Yip, Bon Ham;
Fernandez‐Mercado, Marta;
Woll, Petter S.;
Agirre, Xabier;
Prosper, Felipe;
Jacobsen, Sten E.;
Wainscoat, James S.;
Pellagatti, Andrea;
Boultwood, Jacqueline

Publication type:

Article

Next-generation sequencing - feasibility and practicality in haematology.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 736, doi. 10.1111/bjh.12194

By:

Kohlmann, Alexander;
Grossmann, Vera;
Nadarajah, Niroshan;
Haferlach, Torsten

Publication type:

Article

MLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonism.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 785, doi. 10.1111/bjh.12205

By:

Sison, Edward Allan R.;
Rau, Rachel E.;
McIntyre, Emily;
Li, Li;
Small, Donald;
Brown, Patrick

Publication type:

Article

Haemorrhage and amyloidosis - response to Veneri et al.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 854, doi. 10.1111/bjh.12165

By:

Wettlé, Caroline;
Springinsfeld, Géraldine;
Lipsker, Dan

Publication type:

Article

MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 779, doi. 10.1111/bjh.12175

By:

Hebron, Ellen;
Hope, Chelsea;
Kim, Jaehyup;
Jensen, Jeffrey L.;
Flanagan, Claire;
Bhatia, Neehar;
Maroulakou, Ioanna;
Mitsiades, Constantine;
Miyamoto, Shigeki;
Callander, Natalie;
Hematti, Peiman;
Asimakopoulos, Fotis

Publication type:

Article

Precision medicines for B-cell leukaemias and lymphomas; progress and potential pitfalls.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 725, doi. 10.1111/bjh.12219

By:

Dyer, Martin J. S.;
Vogler, Meike;
Samuel, Jesvin;
Jayne, Sandrine;
Wagner, Simon;
Pritchard, Catrin;
Macip, Salvador

Publication type:

Article

Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 766, doi. 10.1111/bjh.12196

By:

Pessina, Augusto;
Coccè, Valentina;
Pascucci, Luisa;
Bonomi, Arianna;
Cavicchini, Loredana;
Sisto, Francesca;
Ferrari, Maura;
Ciusani, Emilio;
Crovace, Antonio;
Falchetti, Maria Laura;
Zicari, Sonia;
Caruso, Arnaldo;
Navone, Stefania;
Marfia, Giovanni;
Benetti, Anna;
Ceccarelli, Piero;
Parati, Eugenio;
Alessandri, Giulio

Publication type:

Article

Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (Hi DAC) based induction chemotherapy.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 861, doi. 10.1111/bjh.12178

By:

Ling, Victoria;
Burnett, Alan K.;
Bradstock, Ken;
Seymour, John F.;
Hills, Robert K.;
Wei, Andrew

Publication type:

Article

A fibrinogen concentrate Haemocomplettan® (Riastap®) or a Factor XIII concentrate Fibrogammin® combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 806, doi. 10.1111/bjh.12189

By:

He, Shu;
Johnsson, Hans;
Zabczyk, Michal;
Hultenby, Kjell;
Cao, Honglie;
Blombäck, Margareta

Publication type:

Article

Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 798, doi. 10.1111/bjh.12210

By:

Aung, Fleur M.;
Lichtiger, Benjamin;
Bassett, Roland;
Liu, Ping;
Alousi, Amin;
Bashier, Qaiser;
Ciurea, Stefan O.;
Lima, Marcos J.;
Hosing, Chitra;
Kebriaei, Partow;
Nieto, Yago;
Oran, Betul;
Parmar, Simrit;
Qazilbash, Muzaffar;
Shah, Nina;
Khouri, Issa;
Champlin, Richard E.;
Popat, Uday

Publication type:

Article

Works matching IS 00071048 AND DT 2013 AND VI 160 AND IP 6

Identification of novel polymorphism restricted to the (C)ce<sup> s</sup> type 1 haplotype avoids risk of transfusion deadlock in SCD patients.

The actin-binding protein CORO1A is a novel PU.1 ( SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients.

Presenting D-dimer and early symptom severity are independent predictors for post-thrombotic syndrome following a first deep vein thrombosis.

Multiple in silico tools predict phenotypic manifestations in congenital thrombotic thrombocytopenic purpura.

Corrigendum.

Distinct involvement of NF-κB regulators by somatic mutation in ocular adnexal malt lymphoma.

Neutrophil-specific granule deficiency.

Normal prothrombin time in the presence of therapeutic levels of rivaroxaban.

Haemorrhage and amyloidosis.

How I manage priapism due to sickle cell disease.

Multiple cytokine- and chemokine-producing T-cell/histiocyte-rich large B-cell lymphoma.

Single nucleotide polymorphisms and the risk of venous thrombosis: results from a Danish case-cohort study.

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34<sup>+</sup> progenitor cells.

Next-generation sequencing - feasibility and practicality in haematology.

MLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonism.

Haemorrhage and amyloidosis - response to Veneri et al.

MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages.

Precision medicines for B-cell leukaemias and lymphomas; progress and potential pitfalls.

Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice.

Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (Hi DAC) based induction chemotherapy.

A fibrinogen concentrate Haemocomplettan<sup>®</sup> (Riastap<sup>®</sup>) or a Factor XIII concentrate Fibrogammin<sup>®</sup> combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor

Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation.